* Veracyte Inc VCYT.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in December. The mean
expectation of ten analysts for the quarter was for a loss of 15
cents per share.
* Revenue rose 95% to $67.34 million from a year ago;
analysts
expected $61.79 million.
* The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.
* In the last 30 days there have been no negative revisions
of
earnings estimates
* Veracyte Inc shares had fallen by 34.6% this quarter.
* The company reported a quarterly loss of $10.53 million.
* Wall Street's median 12-month price target for Veracyte
Inc is
$53.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
This summary was machine generated March 1 at 12:06 a.m. All
figures in US dollars unless otherwise stated